399 related articles for article (PubMed ID: 26718214)
1. LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells.
Li NS; Zou JR; Lin H; Ke R; He XL; Xiao L; Huang D; Luo L; Lv N; Luo Z
Tumour Biol; 2016 Jun; 37(6):8249-58. PubMed ID: 26718214
[TBL] [Abstract][Full Text] [Related]
2. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.
Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z
Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816
[TBL] [Abstract][Full Text] [Related]
3. Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts.
Lu J; Shi J; Li M; Gui B; Fu R; Yao G; Duan Z; Lv Z; Yang Y; Chen Z; Jia L; Tian L
Life Sci; 2015 Apr; 127():59-65. PubMed ID: 25744403
[TBL] [Abstract][Full Text] [Related]
4. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells.
Cheng K; Hao M
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907
[TBL] [Abstract][Full Text] [Related]
5. Metformin reduces TGF-β1-induced extracellular matrix production in nasal polyp-derived fibroblasts.
Park IH; Um JY; Hong SM; Cho JS; Lee SH; Lee SH; Lee HM
Otolaryngol Head Neck Surg; 2014 Jan; 150(1):148-53. PubMed ID: 24357397
[TBL] [Abstract][Full Text] [Related]
6. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
[TBL] [Abstract][Full Text] [Related]
7. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
8. Activation of AMP-activated protein kinase prevents TGF-β1-induced epithelial-mesenchymal transition and myofibroblast activation.
Thakur S; Viswanadhapalli S; Kopp JB; Shi Q; Barnes JL; Block K; Gorin Y; Abboud HE
Am J Pathol; 2015 Aug; 185(8):2168-80. PubMed ID: 26071397
[TBL] [Abstract][Full Text] [Related]
9. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
[TBL] [Abstract][Full Text] [Related]
11. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
12. AMPK inhibits Smad3-mediated autoinduction of TGF-β1 in gastric cancer cells.
Zou J; Li C; Jiang S; Luo L; Yan X; Huang D; Luo Z
J Cell Mol Med; 2021 Mar; 25(6):2806-2815. PubMed ID: 33538080
[TBL] [Abstract][Full Text] [Related]
13. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
Park CY; Kim DK; Sheen YY
Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
[TBL] [Abstract][Full Text] [Related]
14. Liver Kinase B1/AMP-Activated Protein Kinase Pathway Activation Attenuated the Progression of Endotoxemia in the Diabetic Mice.
Yang Y; Dong R; Hu D; Chen Z; Fu M; Wang DW; Xu X; Tu L
Cell Physiol Biochem; 2017; 42(2):761-779. PubMed ID: 28628912
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.
Nakayama A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2016 Nov; 49(5):1890-1898. PubMed ID: 27599468
[TBL] [Abstract][Full Text] [Related]
16. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
Liu JL; Mao Z; Gallick GE; Yung WK
Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367
[TBL] [Abstract][Full Text] [Related]
17. AMPK reduces macrophage endotoxin tolerance through inhibition of TGF-β1 production and its signaling pathway.
Yin M; Kim J; Choi JI; Bom JS; Bae HB; Jeong S
Int Immunopharmacol; 2023 May; 118():110146. PubMed ID: 37037116
[TBL] [Abstract][Full Text] [Related]
18. Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway.
Wang X; Liu C; Wang J; Fan Y; Wang Z; Wang Y
Oncol Rep; 2017 Feb; 37(2):747-753. PubMed ID: 27959430
[TBL] [Abstract][Full Text] [Related]
19. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
[TBL] [Abstract][Full Text] [Related]
20. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
